Amedica to present clinical trial for CASCADE — 5 notes

Spinal Tech

Amedica will host a conference call and live webcast to present the 24-month clinical results from a blinded, randomized clinical trail for CASCADE.

Here are five notes:

 

1. The CASCADE trial compared spinal fusion between its composite silicon nitride fusion devices with a central, cancellous ceramic core, to the industry standard of PEEK spacers filled with bone autograft.

 

2. Mark P. Arts, MD, PhD, principal investigator and neurosurgeon from the Medical Center Haaglanded in the Netherlands, will present the data.

 

3. B. Sonny Bal, MD, chairman and CEO of Amedica, will discuss the trial results impact on the business.

 

4. The webcast will take place on Mon., March 7, at 2:00 pm EST and can be viewed on Amedica's website.

 

5. Amedica is a company focused on the development and application of interbody implants manufactured with medical-grade silicon nitride ceramic.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers